Navigation Links
Ventus Medical Announces PROVENT(R) Sleep Apnea Therapy Recognized by The Wall Street Journal 2009 Technology Innovation Awards
Date:9/21/2009

BELMONT, Calif., Sept. 21 /PRNewswire/ -- Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.

(Logo:http://www.newscom.com/cgi-bin/prnh/20090409/SF96872LOGO)

"We are excited to be recognized by The Wall Street Journal for our PROVENT Sleep Apnea Therapy," said John McCutcheon, President and Chief Executive Officer at Ventus Medical. "We are proud of this innovative treatment and the potential benefit it brings to the more than 50 million Americans who have obstructive sleep apnea and those not satisfied with standard therapies. We continue our commitment to developing innovative solutions for people affected by sleep-disordered breathing."

According to The Wall Street Journal, winners were selected from nearly 500 nominations across numerous categories from nearly 20 countries. Of those, more than 180 nominations cleared preliminary screening and were passed on for review by a panel of judges comprised of research institutions, venture capital firms and other companies. Judges evaluated whether innovations were truly groundbreaking and also looked at whether their application would be particularly useful in a time of economic hardship. Only seven percent of entries screened by the judges received an award.

About PROVENT Therapy

PROVENT Therapy is a prescription device indicated for the treatment of obstructive sleep apnea (OSA). It is an easy to use and disposable treatment that works across mild, moderate, and severe OSA. The treatment utilizes nasal expiratory positive airway pressure and has been clinically shown to reduce sleep apnea. It incorporates a novel MicroValve design that is placed over the nostrils and secured with hypoallergenic adhesive. During inhalation, the valve opens allowing nearly unobstructed airflow, and during exhalation, the valve closes, limiting airflow through two small openings, which increases expiratory pressure, helping to keep the airway open.

Currently, PROVENT Therapy is available in limited locations in the United States with the assistance and support of professional sleep physicians. PROVENT Therapy may not be appropriate for everyone. For more information, please visit www.ProventTherapy.com.

Sleep-Disordered Breathing

Sleep-disordered breathing broadly refers to a group of disorders characterized by abnormalities of breathing pattern (such as stopping breathing) or the abnormal reduction in the volume of breaths while sleeping. OSA is the most common type of sleep-disordered breathing. An estimated 50 million people in the United States suffer from OSA, which occurs when the upper airway (near the back of the mouth) collapses during sleep, obstructing the airway and preventing air from entering the lungs. OSA is caused by multiple factors, including sleep-induced relaxation of the throat muscles and tongue, enlarged tonsils and adenoids, an abnormally small airway diameter in the back of the mouth and throat, and extra soft tissue in and around the throat due to being overweight.

About Ventus Medical

Ventus Medical is a medical device company focused on improving the lives of patients with sleep-disordered breathing. Located in Belmont, California, Ventus Medical has developed and markets PROVENT Therapy, an innovative, clinically-proven treatment for OSA. Existing OSA solutions do not always meet patients' needs. Through truly innovative technology, solid clinical evidence, and a focus on the patient, Ventus Medical seeks to deliver consumer-preferred, physician-recommended solutions. The company is privately-held and funded by De Novo Ventures, Mohr Davidow Ventures, and Johnson & Johnson Development Corporation.


'/>"/>
SOURCE Ventus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Announces New Opportunity in the United Kingdom
2. Webmedx Launches New Data-Mining Solution for Medical Transcription and Speech-Generated Documents
3. Occlutech and IZASA Obtains Favourable Ruling in Proceeding Initiated by AGA Medical in Spain
4. FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices
5. Adnan H. Tahir, M.D., Named Chief Medical Officer of Sisters of Charity Health System
6. GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care
7. Alere Executive Keynote at DMAA Conference Stresses Combining Medical and Health Improvement Models to Bring About Cost-Effective Changes in Healthcare Reform
8. PLC Medical Systems to Demonstrate RenalGuard(R) at TCT 2009, Building on Success at ESC 2009
9. Motorolas 802.11n Wireless LAN Solution Improves Patient Care and Wireless Security at Memorial Medical Center of Western Michigan
10. Winner Medical Solely Sponsored the 2009 China Medical Textile Industry Forum
11. ATS Medical Announces Implant Milestone for the ATS 3f Aortic Bioprosthesis Achieved at Columbia University Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: